Schmitz, Bettina <br/><br/>
Tolerability and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy and concomitant psychiatric conditions: Post hoc analysis of a prospective, randomized, double-blind trial.  [electronic resource] 

 -  Epilepsy research  01 2020 
 - 106220 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Equivalence Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-6844 
<br/><br/><label>Standard No.: </label>10.1016/j.eplepsyres.2019.106220  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anticonvulsants--administration & dosage<br/>Anxiety--complications<br/>Carbamazepine--administration & dosage<br/>Delayed-Action Preparations--administration & dosage<br/>Depression--complications<br/>Double-Blind Method<br/>Epilepsy--complications<br/>Female<br/>Humans<br/>Lacosamide--administration & dosage<br/>Male<br/>Middle Aged<br/>Sleep Initiation and Maintenance Disorders--complications<br/>Treatment Outcome